Correction: Natural History of Primary Retroperitoneal Extra-Visceral Perivascular Epithelioid Cell Tumors (PEC): A Study from Transatlantic and Australasian Retroperitoneal Sarcoma Working Group (TARPSWG)
Eyal Mor(The University of Melbourne), David Gyorki(The University of Melbourne), Catherine Mitchell(The University of Melbourne), Max Almond(Queen Elizabeth Hospital Birmingham), Giovanni Grignani(Candiolo Cancer Institute), Adam D. Barlow(University of Leicester), Carolyn Nessim(University of Ottawa), Lee D. Cranmer(University of Washington), Sameer Apte, Alessandro Gronchi(Fondazione IRCCS Istituto Nazionale dei Tumori), Markus Albertsmeier(LMU Klinikum), Bruno Vincenzi(Campus Bio Medico University Hospital), Aviram Nissan(Sheba Medical Center), Jason L. Hornick(Harvard University), Emily Z. Keung(The University of Texas MD Anderson Cancer Center), Miguel Henriques Abreu(Universidade do Porto), José Antonio González López(Universitat Autònoma de Barcelona), Michael J. Wagner(Dana-Farber Cancer Institute)
Cited by 0
Related Papers
Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2018|1.6k
Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial
|The Lancet Oncology|2015|1.6k
Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆
|Annals of Oncology|2021|978
Crizotinib in<i>ALK</i>-Rearranged Inflammatory Myofibroblastic Tumor
|New England Journal of Medicine|2010|871